Cancer Diagnostics Market Key Developments 2019: Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers
Biotechnology companies are focusing on the development of genotype- and phenotype-specific drugs for chronic diseases such as cancer in order to ensure that next-generation drugs are more efficacious. Multiplex and multi-analyte biomarkers play an important role in the development of translational medicine, which facilitates the translation of basic research into medical advances. In line with this, most pharmaceutical and biotechnology companies are committing to associate their drugs with diagnostic assays, as a number of multiplex biomarkers are directly associated with...
View full press release